Cazzola M - Search Results

1

Acute exacerbations of COPD: risk factors for failure and relapse.

Mantero M, Rogliani P, Di Pasquale M, Polverino E, Crisafulli E, Guerrero M, Gramegna A, Cazzola M, Blasi F. Mantero M, et al. Among authors: cazzola m. Int J Chron Obstruct Pulmon Dis. 2017 Sep 8;12:2687-2693. doi: 10.2147/COPD.S145253. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28932112 Free PMC article. Review.

2

Advances in the research and development of chemotherapeutic agents for respiratory tract bacterial infections.

Cazzola M, Blasi F, Centanni S, Donner CF, Allegra L. Cazzola M, et al. Pulm Pharmacol Ther. 2001;14(5):367-81. doi: 10.1006/pupt.2001.0302. Pulm Pharmacol Ther. 2001. PMID: 11603950 Review.

3

Therapies in development for community-acquired pneumonia.

Blasi F, Braga P, Cazzola M, Cosentini R, Tarsia P. Blasi F, et al. Among authors: cazzola m. Expert Opin Investig Drugs. 2002 Apr;11(4):545-52. doi: 10.1517/13543784.11.4.545. Expert Opin Investig Drugs. 2002. PMID: 11922862 Review.

4

Have guidelines for the management of community-acquired pneumonia influenced outcomes?

Cazzola M, Centanni S, Blasi F. Cazzola M, et al. Respir Med. 2003 Mar;97(3):205-11. doi: 10.1053/rmed.2003.1352. Respir Med. 2003. PMID: 12645826 Free article. No abstract available.

5

Therapeutic potential of the new quinolones in the treatment of lower respiratory tract infections.

Blasi F, Tarsia P, Cosentini R, Cazzola M, Allegra L. Blasi F, et al. Among authors: cazzola m. Expert Opin Investig Drugs. 2003 Jul;12(7):1165-77. doi: 10.1517/13543784.12.7.1165. Expert Opin Investig Drugs. 2003. PMID: 12831351 Review.

6

Delivering antibacterials to the lungs: considerations for optimizing outcomes.

Cazzola M, Blasi F, Terzano C, Matera MG, Marsico SA. Cazzola M, et al. Am J Respir Med. 2002;1(4):261-72. doi: 10.1007/BF03256617. Am J Respir Med. 2002. PMID: 14720046 Review.

7

Macrolide and occult infection in asthma.

Cazzola M, Matera MG, Blasi F. Cazzola M, et al. Curr Opin Pulm Med. 2004 Jan;10(1):7-14. doi: 10.1097/00063198-200401000-00003. Curr Opin Pulm Med. 2004. PMID: 14749600 Review.

8

Azithromycin and lower respiratory tract infections.

Blasi F, Cazzola M, Tarsia P, Cosentini R, Aliberti S, Santus P, Allegra L. Blasi F, et al. Among authors: cazzola m. Expert Opin Pharmacother. 2005 Oct;6(13):2335-51. doi: 10.1517/14656566.6.13.2335. Expert Opin Pharmacother. 2005. PMID: 16218893 Review.

9

Pharmacodynamics of levofloxacin in patients with acute exacerbation of chronic bronchitis.

Cazzola M, Matera MG, Donnarumma G, Tufano MA, Sanduzzi A, Marchetti F, Blasi F. Cazzola M, et al. Chest. 2005 Oct;128(4):2093-8. doi: 10.1378/chest.128.4.2093. Chest. 2005. PMID: 16236860 Clinical Trial.

10

A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD.

Cazzola M, Andò F, Santus P, Ruggeri P, Di Marco F, Sanduzzi A, D'Amato M. Cazzola M, et al. Pulm Pharmacol Ther. 2007;20(5):556-61. doi: 10.1016/j.pupt.2006.06.001. Epub 2006 Jul 7. Pulm Pharmacol Ther. 2007. PMID: 16914336 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,246 results

Search Page

Filters